Long-Term Assets: The sum of all assets classified as non-current.
Harmony Biosciences Holdings, Inc. (HRMY) had Long-Term Assets of $364.62M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$243.78M |
|
$22.49M |
|
$68.55M |
|
$175.23M |
|
$205.22M |
|
$38.56M |
|
$2.20M |
|
$40.76M |
|
$40.76M |
|
$22.49M |
|
$22.49M |
|
$22.49M |
|
$22.49M |
|
$38.56M |
|
$45.87M |
|
57.49M |
|
58.54M |
|
$0.40 |
|
$0.38 |
|
| Balance Sheet Financials | |
$907.01M |
|
-- |
|
|
Long-Term Assets |
$364.62M |
$1.27B |
|
$252.13M |
|
$143.66M |
|
$149.28M |
|
$401.41M |
|
$870.22M |
|
$780.80M |
|
$870.22M |
|
57.73M |
|
| Cash Flow Statement Financials | |
$348.20M |
|
$-39.65M |
|
$-9.05M |
|
$453.27M |
|
$752.77M |
|
$299.50M |
|
$44.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.60 |
|
-- |
|
-- |
|
0.14 |
|
0.19 |
|
71.88% |
|
15.82% |
|
15.82% |
|
-- |
|
16.72% |
|
9.22% |
|
$347.89M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
12.80 |
|
2.52 |
|
35.73 |
|
2.58% |
|
2.88% |
|
1.77% |
|
2.22% |
|
$15.07 |
|
$5.94 |
|
$5.95 |
|